Vaccines
Latest Stories

An unvaccinated child has died in the Texas measles outbreak
A child who was not vaccinated has died from measles in West Texas.

The flu shot is different this year, thanks to COVID
A strain of influenza appears to have disappeared from the planet since COVID. As a result, U.S. flu vaccines have been redesigned.
COVID-19, RSV, flu: Updated shots are available now in Oregon
Vaccines can protect the youngest and oldest Oregonians from RSV, Covid-19, and the flu this fall.
Think Out Loud
Public health leaders urge vaccination in Oregon’s largest measles outbreak in decades
Oregon is experiencing the worst measles outbreak in the state since the early 1990s. We talk with Paul Cieslak, medical director for the Acute and Communicable Disease Prevention Section at the Oregon Health Authority.

FDA approves updated COVID-19 vaccines, shots should be available in Oregon in 1-3 weeks
Updated COVID-19 vaccines are on their way. The Food and Drug Administration approved new shots from Pfizer and Moderna on Thursday, and the companies are set to begin shipping millions of doses.

OHSU-led research fuels hope for a universal flu vaccine
They say the new approach could lead to the development of a “one and done” shot to cover all flu variants in five years.

Health
Oregon reports sharp rise in whooping cough cases, urges precautions
Pertussis cases in Oregon topped 178 in the latest count. Antibiotics are effective against the respiratory illness, but there’s a catch: They only work when they’re given early in the course of the illness.

Oregon urges families to submit students’ vaccination records by Feb. 21
Children without up-to-date vaccination records will be sent home.

Many at Oregon’s nursing homes haven’t gotten the new COVID booster
The most current state data from October shows that at long-term care facilities, only 6% of staff and 11% of residents have gotten this year's COVID-19 booster.

Health
More newborn shots for RSV come to Oregon, but won’t meet demand, officials say
So far, more than 4,000 infants in Oregon have received Nirsevimab and will have some protection against severe RSV this winter, but many more are eligible and demand has outstripped supply.